Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate MSP1₁₉ expressed in distinct bacterial vectorsCUNHA, Maristela G; RODRIGUES, Mauricio M; SOARES, Irene S et al.Vaccine. 2001, Vol 20, Num 3-4, pp 385-396, issn 0264-410XArticle

On the Cytoadhesion of Plasmodium vivax-Infected ErythrocytesCARVALHO, Bruna O; LOPES, Stefanie C. P; OLIVEIRA, Tatiane R et al.The Journal of infectious diseases. 2010, Vol 202, Num 4, pp 638-647, issn 0022-1899, 10 p.Article

A recombinant vaccine based on domain II of Plasmodium vivax Apical Membrane Antigen 1 induces high antibody titres in miceGENTIL, Fernanda; BARGIERI, Daniel Y; SOARES, Irene S et al.Vaccine. 2010, Vol 28, Num 38, pp 6183-6190, issn 0264-410X, 8 p.Article

Role of interferon-γ during CpG oligodeoxynucleotide-adjuvanted immunization with recombinant proteinsSANTORO ROSA, Daniela; BASTOS, Karina R; YOUSSEF BARGIERI, Daniel et al.Vaccine. 2007, Vol 25, Num 32, pp 6007-6017, issn 0264-410X, 11 p.Article

Plasmodium vivax Duffy binding protein: baseline antibody responses and parasite polymorphisms in a well-consolidated settlement of the Amazon RegionKANO, Flora S; SANCHEZ, Bruno A. M; BRITO, Cristiana F. A et al.TM & IH. Tropical medicine & international health. 2012, Vol 17, Num 8, pp 989-1000, issn 1360-2276, 12 p.Article

Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella TyphimuriumBARGIERI, Daniel Y; LEITE, Juliana A; LOPES, Stefanie C. P et al.Vaccine. 2010, Vol 28, Num 16, pp 2818-2826, issn 0264-410X, 9 p.Article